COVID-19 vaccine was “90% effective” in Phase 3 trial, according to Pfizer and BioNTech.
Pfizer and BioNTech on Monday announced that a jointly-developed COVID-19 vaccine was “90% effective” in ongoing Phase 3 trials.
This, as the joint statement from Pfizer and BioNTech was released on Pfizer’s website as soaring COVID-19 cases across the world had forced millions of people back into lockdown which caused further damage to ravaged economies.
European stock markets and oil prices jumped on the said announcement.
United States President Donald Trump, who lost last week’s election, hailed the said announcement as “such great news”.
Also, World Health Organization (WHO) director Tedros Adhanom Ghebreyesus hailed the COVID-19 vaccine news from the companies as “encouraging“.
READ ALSO: WHO Director Hails Pfizer, BioNTech COVID-19 Vaccine News As ‘Encouraging’
Manila Bulletin reported that according to preliminary findings, protection in patients was achieved 7 days after the second of two doses, and 28 days after the first.
Pfizer and BioNTech said that they expected to supply up to 50 million COVID-19 vaccine doses globally in 2020 and up to 1.3 billion COVID-19 vaccine doses in 2021.
Albert Bourla, the chairman and CEO at Pfizer, said in a statement the first set of results from their Phase 3 COVID-19 vaccine trial provided the initial evidence of their vaccine’s ability to prevent the coronavirus disease.
“We are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis. We are reaching this critical milestone in our vaccine development program at a time when the world needs it most,” Bourla said.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via the official Facebook page and YouTube channel.